Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota.
Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota.
Clin J Am Soc Nephrol. 2022 Oct;17(10):1526-1534. doi: 10.2215/CJN.03400322. Epub 2022 Sep 8.
How maintenance dialysis modality, dialysis setting, and residence in a nursing facility have jointly associated with coronavirus disease 2019 (COVID-19)-related outcomes in the United States is relevant to future viral outbreaks. Using Medicare claims, we determined the incidence of COVID-19-related infection, hospitalization, and death between March 15, 2020 and June 5, 2021. The exposure was one of five combinations of dialysis modality and care setting: in-facility hemodialysis without a recent history of skilled nursing facility care, in-facility hemodialysis with a recent history of skilled nursing facility care, hemodialysis in a skilled nursing facility, home hemodialysis, and (home) peritoneal dialysis. Patient-weeks were pooled to estimate the adjusted associations of event incidence with each dialysis modality/setting during four intervals in 2020-2021. Relative to in-facility hemodialysis without a recent history of skilled nursing facility care, home dialysis was associated with 36%-60% lower odds of all events during weeks 12-23 of 2020; 24%-37% lower odds of all events during weeks 24-37 of 2020; 20%-33% lower odds of infection and hospitalization during the winter of 2020-2021; and similar odds of all events thereafter. In contrast, exposure to skilled nursing facilities was associated with 570%-1140% higher odds of all events during spring of 2020, although excess risk attenuated as the pandemic transpired, especially among patients who received hemodialysis in skilled nursing facilities. In conclusion, home dialysis was associated with lower risks of COVID-19 diagnosis, hospitalization, and death until vaccines were available, whereas care in skilled nursing facilities was associated with higher risks.
在美国,维持透析方式、透析环境和居住在护理机构如何共同与 2019 年冠状病毒病(COVID-19)相关结局相关,这对未来的病毒爆发具有重要意义。利用医疗保险索赔数据,我们确定了 2020 年 3 月 15 日至 2021 年 6 月 5 日期间与 COVID-19 相关的感染、住院和死亡的发生率。暴露因素为透析方式和护理环境的五种组合之一:无近期护理机构护理史的机构内血液透析、有近期护理机构护理史的机构内血液透析、护理机构内血液透析、家庭血液透析和(家庭)腹膜透析。将患者周合并以估计在 2020-2021 年四个时间段内每种透析方式/环境与事件发生率的调整关联。与无近期护理机构护理史的机构内血液透析相比,家庭透析与 2020 年第 12-23 周所有事件的可能性降低 36%-60%;与 2020 年第 24-37 周所有事件的可能性降低 24%-37%;与 2020-2021 年冬季感染和住院的可能性降低 20%-33%;此后发生所有事件的可能性相似。相比之下,在 2020 年春季,暴露于护理机构与所有事件的可能性增加 570%-1140%相关,尽管随着大流行的发展,风险增加逐渐减弱,尤其是在接受护理机构内血液透析的患者中。总之,在疫苗可用之前,家庭透析与 COVID-19 诊断、住院和死亡的风险降低相关,而在护理机构接受护理则与更高的风险相关。